Martin Samuel Bates's Form 4 filing
Celldex Therapeutics, Inc. (CLDX) · filed Aug 15, 2022
- Accession no.
- 0001415889-22-008608
- Filed
- Aug 15, 2022
- Trade date
- Aug 11-12, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 3 derivative transactions. Open-market sales total $730.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Martin Samuel BatesCIK 0001709024 | Officer (SVP AND CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2022 | Common Stock | MOption exerciseAcquired | +2,453 | $9.02 | +$22,126.06 | 26,831 | Direct | |
| Aug 11, 2022 | Common Stock | SSaleDisposed | −2,453 | $37.04 | −$90,859.12 | 24,378 | Direct | |
| Aug 12, 2022 | Common Stock | MOption exerciseAcquired | +3,876 | $9.02 | +$34,961.52 | 28,254 | Direct | |
| Aug 12, 2022 | Common Stock | MOption exerciseAcquired | +13,671 | $2.78 | +$38,005.38 | 41,925 | Direct | |
| Aug 12, 2022 | Common Stock | SSaleDisposed | −14,261 | $36.76 | −$524,234.36 | 27,664 | Direct | |
| Aug 12, 2022 | Common Stock | SSaleDisposed | −2,065 | $35.38 | −$73,059.7 | 25,599 | Direct | |
| Aug 12, 2022 | Common Stock | SSaleDisposed | −1,221 | $34.62 | −$42,271.02 | 24,378 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2022 | Common Stock | MOption exerciseDisposed | −2,453 | $0.00 | $0 | 7,077 | Direct | |
| Aug 12, 2022 | Common Stock | MOption exerciseDisposed | −3,876 | $0.00 | $0 | 3,201 | Direct | |
| Aug 12, 2022 | Common Stock | MOption exerciseDisposed | −13,671 | $0.00 | $0 | 10,750 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.